Loading...
UK Trademark — IPO
AERVIXA
Application UK00004355693 · Application Published
Quick Facts
| Application Number | UK00004355693 |
| Status | Application Published |
| Owner | Glenmark Pharmaceuticals s.r.o. |
| Filed | 2026-03-16 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
AERVIXA has a current status of Application Published.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceuticals; pharmaceutical and medical preparations; respiratory stimulants; compounds for treating respiratory diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of diseases of the respiratory system.
Class 10 — Medical Devices
Pharmaceutical and medical devices; pharmaceutical and medical instruments; surgical and medical apparatus and instruments; masks and equipment for artificial respiration.
Timeline
- Filed: 2026-03-16
- First published: 2026-03-27 (Journal 2026/013)
About This Trademark
'AERVIXA' is a application published trademark on the UK IPO register, owned by Glenmark Pharmaceuticals s.r.o.. The application (UK00004355693) was filed on 16 March 2026.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus).
The trademark is represented by Boult Wade Tennant LLP.
Frequently Asked Questions
Who owns UK trademark UK00004355693 ('AERVIXA')?
UK trademark UK00004355693 for the mark 'AERVIXA' in Class 5, 10 is recorded on the UK IPO register as owned by Glenmark Pharmaceuticals s.r.o.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00004355693 currently a registered trademark?
No — the UK IPO records the status of UK trademark UK00004355693 for the mark 'AERVIXA' as application published.
Which Nice classes is UK trademark UK00004355693 registered under?
UK trademark UK00004355693 for the mark 'AERVIXA' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus). The filed specification reads: Class 5: Pharmaceuticals; pharmaceutical and medical preparations; respiratory stimulants; compounds for treating respiratory diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; Inhaled pharmaceutical preparations for the treatment of re…
When was UK trademark UK00004355693 filed?
UK trademark UK00004355693 for the mark 'AERVIXA' was filed at the UK IPO on 16 March 2026.
When was UK trademark UK00004355693 published?
The UK IPO first published / advertised UK trademark UK00004355693 for the mark 'AERVIXA' on 27 March 2026.
Who is the attorney of record for UK trademark UK00004355693?
Boult Wade Tennant LLP is listed as the attorney / representative of record for UK trademark UK00004355693 for the mark 'AERVIXA' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.